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Abstract 
Background 
 Empirical evidence suggests that prenatal growth is associated with attention 
deficit/hyperactivity disorder (ADHD) and its symptoms. Data on the importance of postnatal 
growth is, however scanty. We studied whether pre- and postnatal growth up to 56 months is 
associated with symptoms of ADHD in children. 
Method 
A longitudinal regional birth cohort study comprising 893 children followed up to 56 months. 
The associations between pre- and postnatal growth and parent-rated ADHD symptoms of the 
child were analyzed with multiple linear regression analyses and repeated-measures analyzes of 
covariance. 
Results 
Children born lighter, thinner, shorter, and with a smaller head circumference, adjusted for 
length of gestation, received higher parent-rated ADHD symptoms scores at 56 months. Further, 
smaller head circumference throughout the period of growth from birth up to 56 months was 
related to higher ADHD symptoms scores. The associations changed only little after adjusting 
for several pre- and neonatal factors. The associations were not modified by sex and there were 
no evidence of non-linear associations.  
Conclusions 
Slower prenatal growth in weight, body-mass index, length, and head circumference may pose a 
risk for higher ADHD symptoms in childhood. The consistently smaller head circumference 
from birth up to 56 months characterizing children with higher ADHD symptoms may point to a 
lack of catch-up growth in head circumference in childhood as a predisposing factor.  
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Background 
Attention deficit/hyperactivity disorder (ADHD) is among the most common neuropsychiatric 
disorders in childhood with a worldwide prevalence rate of approximately 5% [1]. Behavioral 
symptoms characterizing ADHD are even more common, and include inattention, hyperactivity, 
and impulsiveness [2]. The etiology of ADHD is multifaceted. Together with genetic and 
environmental factors both pre- and postnatal growth may influence its development [3, 4]. 
Indeed, mounting empirical evidence shows that prematurity and small body size at birth are 
associated with ADHD and its symptoms [5-11]. The evidence for the importance of postnatal 
growth is, however scanty and often confounded by stimulant medication used in treating ADHD 
symptomatology; stimulant-medication may per se compromise physical growth. Thus, it 
remains unknown if postnatal growth is etiologically associated with ADHD or is a consequence 
of the stimulant-medication [12]  
In stimulant-naïve child and adolescent samples, those who gain higher scores in ADHD 
symptoms or who fulfill the criteria of the disorder have in cross-sectional studies been shown 
both to be shorter [13, 14] or taller [15, 16], to have higher weight [16] and both to have a lower 
[17] or a higher [16, 18, 19] body-mass index (BMI). Yet, to our knowledge only two studies to 
date have addressed the role of physical growth in ADHD: the first compared growth of 48 boys 
with ADHD in relation to population norms and found a distinct suppression of growth in height 
from 9 to 14 years, earlier onset of adolescent growth spurt and a higher velocity of growth in 
that moment [15]. The second study showed in 87 extremely-low-birth-weight boys and girls that 
growth in head circumference between birth and two years did not predict parent/teacher-rated 
ADHD at school-age [20].The current study will test  if growth in height, weight, BMI and head 
circumference from birth up to five, 20, and 56 months of age is associated with parent-rated 
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ADHD symptoms at 56 months. Thus, the current study will add new information of the 
association between the postnatal growth from birth to preschool-age and symptoms of ADHD in 
a stimulant-naïve sample of girls and boys. By using different time points and a range of 
anthropometric measurements the study will also show whether there are particular periods of 
growth or measures that are specifically related to symptoms of ADHD.  
 
Methods 
Participants 
The study cohort comprised infants participating in the Arvo Ylppö Longitudinal Study (AYLS) 
[21, 22]. Of a total of 15,311 deliveries in the seven maternity hospitals in the county of 
Uusimaa, Finland, we identified all live-born infants between March 15, 1985 and March 14, 
1986 who were admitted to the neonatal wards of the obstetric units or transferred to the 
Neonatal Intensive Care Unit of the Hospital for Children and Adolescents, University of 
Helsinki, within 10 days of birth. The population ranged from severely ill preterm infants to 
infants born at term requiring only brief inpatient observation. In total, there were 1,535 admitted 
infants (n = 867 boys). In addition, 658 infants (n = 328 boys), born during the same period but 
not admitted to the neonatal ward, were randomly recruited from the three largest maternity 
hospitals in the study area. Participants were invited to clinical follow-ups at 5 and 20 months of 
corrected age and at 56 months of age. The study protocol was approved by the Ethical 
Committees of Helsinki City Maternity Hospital, Helsinki University Central Hospital, and Jorvi 
Hospital, and the parent(s) gave their informed consent. 
Of the 2,193 infants 2,125 survived to 56 months of age. We excluded 80 infants with 
congenital malformations and chromosomal abnormalities, and Mendelian disorders potentially 
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affecting growth. At least one birth size measure, control variable and/or parental ratings of 
ADHD at 56 months was lacking for 1,232 children. Thus, the participants in the present study 
included 893 children: boys (n = 490) and girls (n = 403). The original cohort is described in 
detail elsewhere [22, 23].   
The study participants (n = 893) did not differ from those who were lost to follow-up due 
to lack of information on any birth size measure, gestational age and/or pre- and neonatal control 
variables (n = 225) in sex, multiple pregnancy, mother’s height, on BMI at five months, or in any 
body size measures at 20 and 56 months (all p-values > .05). However, those lost to follow-up 
were more likely to have been admitted to a neonatal ward, to come from less educated families, 
to have younger mothers, and mothers who smoked more during pregnancy. Furthermore, they 
were lighter, shorter and had smaller head circumference at birth, and at 5 months, and were also 
thinner at birth, born earlier and less likely to be breast fed (all p-values < .04). Further, the study 
participants (n = 893) did not differ from those who were lost to follow-up due to lack of 
information on parental rated ADHD symptoms (n = 927) in any body size or control variables, 
except that those who did not had ADHD symptoms scores available were shorter at 5 and 20 
months and their mothers had smoked more during pregnancy (p-values < .049). As the ADHD 
symptoms were measured at the age of 56 months the participants were not yet treated with 
stimulant medication, even if symptoms of ADHD might already be present.  
 
Measures 
Body size at birth, and in infancy and childhood  
Data on the newborns’ date of birth, weight (g), length (cm) and head circumference (cm) were 
extracted from hospital birth records, and BMI was calculated (kg/m
2
). The same anthropometric 
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measures were taken during the clinical visits at five and 20 months of corrected age and at 56 
months.   
Growth  
The growth variables were the standardized residuals from the linear regression models where 
body size at each time point was regressed on corresponding size measures at all earlier time 
points, thus creating completely uncorrelated residuals reflecting growth conditional on previous 
history. The residuals provided information on whether growth by a particular age was faster or 
slower than would have been predicted from previous measurements. 
Gestational age 
Gestational age was determined from the date of the mother’s last menstrual period and/or 
ultrasound examination. All the infants were given an assessment of clinical maturity [24] . 
When there was a difference in the estimates of more than two weeks, gestational age was 
corrected according to Dubowitz maturity scale, except for preterms under 32 weeks of 
gestational age. 
Parental Ratings of ADHD symptoms 
At the 56-month follow-up the parents evaluated the child’s ADHD symptoms with the Conners’ 
Hyperactivity Index –parent version [25]. This index is composed of ten items rated on a four-
point scale (0 = not at all to 3 = very much). Sample items are: ”Inattentive, easily distracted” 
and ”Restless or overactive”. The items were summed with higher scores reflecting higher levels 
of ADHD symptoms. Cronbach’s alpha was .85.  
Potential covariates 
We tested if the associations between body size/growth variables and ADHD symptoms were 
confounded by the child’s sex, gestational age, admission to neonatal ward during the first ten 
days, multiple pregnancy (singleton vs. multiple), mother’s smoking during pregnancy (none, 1-
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10, >10 cigarettes/day), parental education (four point scale of highest self-reported level of 
education of either parent: from high = university education to low = elementary school 
education or less), maternal age (years), maternal height (cm). 
 
Statistical analysis 
Body size at birth and at five, 20, and 56 months of age was converted into z scores (Mean = 0; 
Standard Deviation (SD) = 1) by sex, and birth size measures additionally by gestational age. 
The standardized scores represent the difference from mean value for the sample of control 
children participating in the current study (i.e. those who were not admitted to neonatal ward). 
As the primary data analytical tool, we used multiple linear regression analysis. We 
examined, first, if body size at birth, and at five, 20 and 56 months, and, second, if growth from 
birth to five, 20 and 56 months of age, conditional on previous history, predicted the child’s 
ADHD symptoms at 56 months as a continuous score. As the associations are not necessarily 
linear, we also tested the potential non-linearity of the associations by entering squared terms of 
body size at each time point into the regression equation following the linear terms.  
Finally, we examined trajectories of growth by using repeated-measures analysis of 
covariance (ANCOVA). In the ANCOVA body size at birth, five, 20 and 56 months of age 
represented the within-person dependent variables, and quintiles of ADHD symptoms at 56 
months represented the independent between-person grouping variable. All associations were 
tested after controlling for the sex of the child, and then further controlling for pre- and neonatal 
covariates.  
We also re-ran analyzes in a subgroup of children not admitted to neonatal ward during 
first 10 days, and who had birth weight ≥ 2,500g and were born at term (≥ 37 weeks of 
gestation). This remaining subgroup included 293 children.  
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Results 
 
Table 1 shows characteristics of the sample divided by sex. Compared with girls, boys had 
higher scores on ADHD-symptoms at 56 months.  Boys were bigger at all measurement points 
and were more likely to have been admitted to a neonatal ward. In addition, we tested 
interactional effects of sex by adding an interaction term ‘sex x body size (each anthropometric 
variable at each time point in separate models)’ into the regression equation in addition to the 
main effects of these two centered variables in predicting ADHD-symptoms. These analyses 
revealed no significant interactions (all p-values > .13). All the main results are presented in the 
pooled sample. When testing for associations between covariate variables and ADHD-symptoms, 
we found that after controlling for the child’s sex, children of younger mothers, and of parents 
with a lower educational level had higher ADHD-symptoms scores (p-values < .002; all other p-
values > .13).  
 
Relative body size and parent-rated ADHD symptoms at 56 months 
Table 2 shows that lower weight, shorter length, smaller head circumference and lower BMI at 
birth were significantly associated with higher ADHD symptoms scores after controlling for 
child’s sex. Table 2 also shows that smaller head circumference at five, 20 and 56 months of age 
were significantly associated with higher ADHD symptoms scores. After controlling for pre- and 
neonatal covariates, the association between head circumference at 20 months and ADHD 
symptoms were rendered to marginal significance (from p = .02 to p = .08), whereas the 
previously marginally significant association between lower BMI at 56 months and higher 
ADHD symptoms became significant (from p = .09 to p = .04).  
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Growth and parent-rated ADHD symptoms at 56 months 
Growth conditional on history 
After controlling for child’s sex there were no significant associations between growth 
(conditional on history) and ADHD symptoms. However, after controlling for the rest of the 
covariates the previously marginally significant association (p = 0.06) between a slower gain in 
BMI from 20 to 56 months and higher ADHD symptoms scores became significant (B = -0.37, 
95% Confidence Interval (CI): -0.70 to -0.32, p = .03) (Table 3.). 
Growth trajectories 
Figure 1 displays the growth trajectory of head circumference in quintiles of ADHD symptoms 
scores in a fully controlled model. The pattern of the growth trajectory across time was not 
significantly different between the ADHD symptoms group (ADHD grouping x time, p = .93). 
However, children who had ADHD symptoms scores in the highest quintile displayed the lowest 
head circumference and children having the lowest ADHD symptoms scores displayed the 
highest head circumference from birth to 56 months (Mean difference in SD units = 0.27, 95% 
CI = 0.06 to 0.49, p = .01). Head circumferences of the children with ADHD symptoms scores in 
the middle three quintiles fell between these two extreme quintiles. The analyses of other growth 
measures by quintiles of ADHD symptoms were not statistically significant.  
 
Associations in a subgroup of full term and normal birth weight children not admitted to 
neonatal ward 
Finally, we tested whether the observed results remained similar in a subgroup of children who 
were not admitted to the neonatal ward, had birth weight ≥ 2,500g and were born at term (≥ 37 
weeks of gestation) (n=293). We found that in a fully controlled model lower weight (p=0.005), 
smaller head circumference (p=0.06) and lower BMI (p=0.001) at birth were significantly or 
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marginally significantly associated with higher ADHD symptoms scores. However, birth length 
was not associated with the ADHD symptoms (p=0.27). Further, smaller head circumference at 
five (p=0.05), 20 (p=0.04) and 56 months of age (p=0.03) were associated with higher ADHD 
symptoms scores. None of the previously found associations between relative BMI at 56 months 
and growth in BMI from 20 to 56 months and ADHD symptoms were present in this subgroup. 
Finally, the growth trajectory of head circumference in quintiles of ADHD symptoms scores was 
similar to that found in a total sample. Children who had ADHD symptoms scores in the highest 
quintile displayed the lowest head circumference and children having the lowest ADHD 
symptoms scores displayed the highest head circumference from birth to 56 months (Mean 
difference in SD units = 0.37, 95% CI = 0.02 to 0.72, p = .04). 
 
Discussion 
We found in a sample of 893 Finnish children that those born lighter in weight, thinner in BMI, 
shorter in stature and smaller in head circumference were rated by their parents as having higher 
ADHD symptoms scores at 56 months. Further, we found that a smaller head circumference 
throughout the period of growth from birth to 56 months was related to higher ADHD symptoms. 
We also found that a slower gain in BMI from 20 to 56 months and a lower relative BMI at 56 
months was associated with higher ADHD symptoms. Controlling for several pre- and neonatal 
covariates had little effect on the results. The associations were not modified by sex and there 
were no non-linear associations. 
We also found a similar pattern of findings in a subgroup of term (≥ 37 weeks of 
gestation), normal birth weight (≥ 2,500g) children not admitted to neonatal ward (n=293) with 
three clear exceptions: the association between birth length, growth in BMI from 20 to 56 
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months and the relative BMI at 56 months and ADHD symptoms scores were turned to non-
significant. 
 There are several strengths in this study.  We were able to examine the early childhood 
growth using multiple anthropometric variables in a prospective study design. Most of the 
existing studies have been conducted with data derived from clinical practice, which may favor a 
higher than expected rate of positive findings [26]. Also studies with stimulant-naïve sample are 
needed to evaluate whether potential growth deficits may indeed be etiologically related to 
ADHD and not a consequence of stimulant-medication used to treat symptomatology [12]. 
Further, we had the whole birth weight range available and could control for several variables 
that may have an impact on growth and/or ADHD symptoms. Controlling for covariates 
increases the likelihood that the findings are true and not due any confounding factor related to 
the both independent and dependent variables. We could also exclude children with severe 
conditions that could have potentially confounded the findings. 
 There are also some limitations. For practical reasons, several parents did not receive or 
fill in the ADHD questionnaire. However, those who did and did not receive/fill in the 
questionnaire did not differ from each other in most of the measured variables. However, 
compared to those lost to follow-up the participants were taller at five and at 20 months, and 
their mothers smoked less during pregnancy. Therefore, the results may be more characteristic of 
children exposed to less adverse pre- and postnatal environments. Further, we had no 
information on the parental ADHD symptoms and were, thus, unable to take potential genetic 
susceptibility into account. Neither, did we have information on environmental postnatal factors 
as non-optimal parenting [27, 28] and family adversity [29] that have been shown to be related to 
symptoms of ADHD. However, we have controlled for parental education, which is a crude 
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proxy of several environmental adversities. As we have used multiple measures of body size at 
four different time points, we have ended up making multiple tests. However, we decided not to 
use the correction for multiple testing (e.g., Bonferroni correction). First, as the number of Type I 
errors cannot decrease without increasing type II errors [30]. Second, theoretical assumption 
behind the correction of multiple testing is that all null hypotheses are true simultaneously, 
which was not of interest of our study. It is suggested simply describing carefully the used 
analyses is usually the most rational way of dealing with multiple testing [31].   
We have previously shown with the same data that small for gestational age (SGA) 
status, rather than prematurity per se, may increase risk for symptoms of ADHD in young 
children [9]. While current findings showing associations between smaller body size in weight, 
length, head circumference and BMI at birth and higher ADHD symptoms scores are in 
accordance with our and majority of others previous findings [5-8, 10, 11], they also extend them 
in significant ways. Of the few previous studies focusing on children born across the whole 
gestational age/birth weight range [e.g., 9, 32] to our knowledge none has focused on birth 
weight, length, head circumference and BMI in a same study. In our cohort, birth weight and 
head circumference seem to have the strongest associations with parent rated ADHD symptoms.  
 With regard to postnatal growth, to our knowledge there are only three prior studies 
focusing on postnatal head circumference and ADHD or its symptoms. Ptcak et al. [33] 
suggested that 4-16 years-old boys with diagnosed ADHD have a smaller head circumference 
than the normal non-clinical population, although the association was only marginally significant 
among those boys who did not receive medication (n = 52, p = .07). Hack et al. [34] found 
among 249 very-low-birth-weight children that those who had a subnormal head size (less than 
the mean -2 SD for age) at 8 months of corrected age had a higher incidence of hyperactivity at 
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8-9 years. This association became, however, non-significant after controlling pre- and neonatal 
covariates. Finally, Stathis et al. [20] failed to find any significant associations among 87 
extremely-low-birth weight born children between subnormal head circumference (comparison 
to norm z-scores) or head growth velocity from birth to 2 years and parent/teacher rated ADHD 
diagnoses at school-age. Because of differences in age of the samples and periods of growth, 
direct comparison of our results showing an association between a smaller head circumference 
throughout the period of growth from birth to 56 months with higher levels of ADHD symptoms 
at 56 months, with earlier findings is not possible. The current study is the only one that presents 
results in a relatively large cohort of children born across the whole birth weight range.  
 The mechanisms explaining the association between postnatal head circumference and 
ADHD symptoms remain speculative. Head circumference has been shown to correlate highly 
with total brain volume (from 1.7 to six years r = .93) [35]. Smaller total brain volume, in turn, 
has been shown to be related to ADHD in several studies [36]. Further, our results showing that 
those having the highest levels of parent rated ADHD symptoms were those who had the smaller 
head circumferences already at birth and had a persistently smallest head circumference across 
the early childhood pointing, at least partly, to the compromised prenatal period the effects of 
which the postnatal growth has not been able to correct. The longitudinal growth curves of total 
brain volumes have been shown to be roughly parallel, although at different levels, between 
patients with ADHD and healthy controls [37] suggesting that developmental processes are 
essentially healthy in ADHD, and that ADHD symptoms appear to reflect fixed earlier 
neurobiological insults or abnormalities. Another study [38] provided evidence that the pattern of 
brain maturation in ADHD was delayed, rather than abnormal. As the brain volume usually 
reaches its maximum volume by early adolescence [39] the age range of the participants in the 
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current study does not allow conclusions whether the association between smaller head 
circumference and higher levels of ADHD symptoms reflect slow maturation that will disappear 
later.  
We also found that lower relative BMI at 56 months and slower gain in BMI from 20 to 
56 months was related to higher ADHD symptoms. Earlier studies have shown that ADHD or its 
symptoms are associated with higher BMI [16, 18, 19] rather than with thinness [17], or have not 
found associations with BMI [14, 40, 41].  All previous studies have, however, studied older 
participants or used diagnoses of ADHD. It should also be noted that our results became non-
significant after excluding the participants who were admitted to neonatal ward during first ten 
days, were born preterm or had a birth weight < 2,500 g suggesting the stronger relationship 
among those born with compromised prenatal period or early health problems. However, our 
findings of slower gain in BMI may also reflect the measurement period from 20 to 56 months. 
At that time children start to move more by themselves. They may burn a lot of energy while 
hyperactive, but the ADHD-related abnormal eating behaviors (e.g. binge eating) that are present 
in older individuals may only have a minor role on the choices and amount of food consumed  
see
 
[42].  
Earlier studies on height and ADHD have been mainly cross-sectional and inconsistent in 
their findings [13-16, 43]. The one existing longitudinal study focusing on growth in height 
among 48 ADHD diagnosed boys from two to 17 years of age found a distinct suppression of 
growth in height from nine to 14 years, earlier onset of adolescent growth spurt and a higher 
velocity of growth in that moment  [15]. That study however differed from the current study in 
measurement of ADHD and in age range. Our longitudinal findings that parental rated ADHD 
symptoms at 56-months are not related to relative height at successive time points or to growth 
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trajectories during the first years extend the knowledge of prior studies to years before ADHD-
diagnoses are usually made. 
 
Conclusions 
In summary, the results point to the importance of a slower prenatal growth. The consistently 
smaller head circumference from birth to 56 months characterizing children with higher ADHD 
symptoms scores may point to the importance of a lack of catch-up growth in head in childhood 
as another predisposing factor. However, it should be kept in mind that the associations we found 
were relatively modest in effect size. Measurements of body size are nevertheless crude 
measurements of environmental conditions early in life, and any association may give a hint of a 
biologically significant relationship. Further, studies are clearly needed to illuminate the 
association between growth and ADHD throughout the entire period of growth. 
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Figures 
 
Figure 1 - Head circumference up to 56 months of age and Attention-Deficit/Hyperactivity 
Disorder (ADHD) symptoms.  
The associations between head circumference (Standard Deviation (SD) scores) at birth, and at 
five, 20 and 56 months age and parent rated ADHD symptoms as quintiles after controlling for 
child's sex, gestational age, admission to neonatal ward, multiple pregnancy, mother’s smoking 
during pregnancy, parental education, maternal age, and maternal height. 
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Table 1. Characteristics of the sample by sex.        
   Boys    Girls   
    n Mean (SD)/ n (%) n Mean (SD)/ n (%)   
Parental rated ADHD-symptoms 490 9.5 5.0  403 8.4 4.7 * 
Body size         
At birth         
 Weight, kg 490 3.4 0.8  403 3.3 0.7 * 
 Length, cm 490 49.6 3.6  403 48.7 3.2 * 
 Head circumference, cm 490 35.0 2.2  403 34.3 2.1 * 
 BMI, kg/m
2
 490 13.5 1.8  403 13.5 1.8  
At 5 months          
 Weight, kg 482 7.6 0.9  394 7.0 0.9 * 
 Length, cm 478 66.5 2.3  388 64.5 2.2 * 
 Head circumference, cm 480 43.6 1.2  391 42.3 1.1 * 
 BMI, kg/m
2
 476 17.2 1.5  388 16.8 1.5 * 
At 20 months         
 Weight, kg 457 12.1 1.4  376 11.4 1.4 * 
 Height, cm 444 84.6 3.1  369 83.2 3.2 * 
 Head circumference, cm 459 49.4 1.4  381 48.1 1.2 * 
 BMI, kg/m
2
 440 16.8 1.4  369 16.4 1.3 * 
At 56 months         
 Weight, kg 482 18.5 2.6  393 17.8 2.7 * 
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 Height, cm 470 108.6 4.4  390 107.3 4.6 * 
 Head circumference, cm 476 52.3 1.5  392 51.0 1.3 * 
 BMI, kg/m
2
 469 15.6 1.5  387 15.4 1.5 * 
Covariates         
Gestational age, weeks 490 38.4 2.8  403 38.7 2.6  
Admission to neonatal ward (n, %) 490 341 69.6  403 251 62.3 * 
Multiple pregnancy (n, %) 490 21 4.3  403 21 5.2  
Maternal smoking during pregnancy (n, %) 490    403    
 > 10 cigarettes/day  27 5.5   25 6.2  
 1-10 cigarettes/day  82 16.7   71 17.6  
 None  381 77.8   307 76.2  
Mother's          
 Height, cm 490 164.4 5.4  403 164.3 5.5  
 Age, Years 490 29.4 5.1  403 29.4 5.0  
Parental education (n, %) 490    403    
 I  58 11.8   48 11.9  
 II  171 34.9   154 38.2  
 III  151 30.8   107 26.6  
 IV  110 22.4   94 23.3  
Breast fed (yes: n, %) 490 457 93.3  403 378 93.8  
         
Note. ADHD=Attention-Deficit/Hyperactivity Disorder,  BMI=Body-mass index,  
Parental education I=Low to IV=High, * P < 0.05.   
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Table 2.  Relative body size at birth, and up to 56 months of age and ADHD-symptoms.  
    Model I      Model II    
    
Effect size 
in SD units (95% CI) 
P-
value   
Effect size 
in SD units (95% CI) 
P-
value  
At birth         
 Weight -0.39 (-0.65 to -0.13) 0.003  -0.41 (-0.69 to -0.14) 0.003  
 Length -0.32 (-0.58 to -0.06) 0.02  -0.33 (-0.61 to -0.05) 0.02  
 Head circumference -0.40 (-0.68 to -0.12) 0.01  -0.36 (-0.65 to -0.07) 0.01  
 BMI -0.33 (-0.59 to -0.07) 0.01  -0.33 (-0.60 to -0.06) 0.02  
At 5 months          
 Weight -0.16 (-0.45 to 0.13) 0.28  -0.19 (-0.53 to 0.15) 0.27  
 Length -0.12 (-0.42 to 0.18) 0.44  -0.1 (0.46 to 0.26) 0.57  
 Head circumference -0.39 (-0.69 to -0.10) 0.01  -0.31 (-0.61 to -0.01) 0.04  
 BMI -0.13 (-0.43 to 0.16) 0.37  -0.17 (-0.50 to 0.15) 0.29  
At 20 months         
 Weight -0.11 (-0.43 to 0.21) 0.49  -0.13 (-0.46 to 0.20) 0.44  
 Length -0.05 (-0.36 to 0.26) 0.73  -0.02 (-0.35 to 0.31) 0.90  
 Head circumference -0.36 (-0.68 to -0.05) 0.02  -0.29 (-0.61 to 0.04) 0.08  
 BMI -0.14 (-0.46 to 0.19) 0.42  -0.19 (-0.52 to 0.14) 0.26  
At 56 months         
 Weight -0.04 (-0.36 to 0.25) 0.72  -0.1 (-0.43 to 0.24) 0.57  
 Length 0.09 (-0.22 to 0.40) 0.56  0.15 (-0.20 to 0.51) 0.40  
 Head circumference -0.40 (-0.71 to -0.10) 0.01  -0.34 (-0.65 to -0.03) 0.03  
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  BMI -0.27 (-0.57 to 0.04) 0.09   -0.34 (-0.67 to -0.01) 0.04  
Note: ADHD=Attention-Deficit/Hyperactivity Disorder,  BMI=Body-mass index 
Model I: After controlling for child's sex; Model II: after controlling for child's sex, gestational age, 
admission to neonatal ward, multiple pregnancy, mother’s smoking during pregnancy, 
 parental education, maternal age, and maternal height.   
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Table 3. Associations between growth (conditional on history) and parental rated symptoms 
of Attention deficit/hyperactivity disorder (ADHD).  
Growth variable Parental rated symptoms of ADHD, 
Unstandardized regression coefficient (95% CI) 
 Model I Model II 
Weight   
 At birth -0.37 (-0.64 to -0.09)* -0.37 (-0.66 to -0.08)* 
 Growth from birth to 5 months 0.02 (-0.33 to 0.37) -0.01 (-0.36 to 0.34) 
 Growth from 5 to 20 months  0.11 (-0.22 to 0.43) 0.09 (-0.24 to 0.41) 
 Growth from 20 to 56 months -0.03 (-0.36 to 0.30) -0.09 (-0.42 to 0.24) 
Length/height   
 At birth -0.29 (-0.56 to -0.01)* -0.28 (-0.57 to 0.02) 
 Growth from birth to 5 months 0.12 (-0.24 to 0.49) 0.12 (-0.25 to 0.48) 
 Growth from 5 to 20 months  0.03 (-0.29 to 0.36) 0.06 (-0.27 to 0.39) 
 Growth from 20 to 56 months 0.11 (-0.24 to 0.45) 0.07 (-0.27 to 0.42) 
Head circumference   
 At birth -0.37 (-0.67 to -0.07)* -0.33 (-0.63 to -0.02)* 
 Growth from birth to 5 months -0.18 (-0.52 to 0.16) -0.15 (-0.49 to 0.20) 
 Growth from 5 to 20 months  -0.23 (-0.58 to 0.12) -0.19 (-0.54 to 0.16) 
 Growth from 20 to 56 months -0.25 (-0.59 to 0.10) -0.25 (-0.59 to 0.09) 
Body-mass-index   
 At birth -0.22 (-0.50 to 0.05) -0.22 (0.51 to 0.07)* 
 Growth from birth to 5 months -0.02 (-0.36 to 0.32) -0.08 (-0.41 to 0.27) 
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 Growth from 5 to 20 months  0.07 (-0.27 to 0.41) 0.03 (-0.31 to 0.37) 
 Growth from 20 to 56 months -0.31 (-0.65 to 0.02) -0.37 (-0.70 to -0.03)* 
Note. Birth size, growth rates from birth to 5 months, from 5 to 20 months, and from 20 to 56 
months are considered simultaneously. The growth variables are expressed as standardized residuals 
of regression of size at each age stage on size at previous age stage(s), that is, growth conditional on 
history. Model Il includes adjustments for child’s sex; Model II includes adjustments for child’s sex, 
gestational age, admission to neonatal ward during the first ten days, multiple pregnancy, mother’s 
smoking during pregnancy, parental education, maternal age and maternal height. * P< 0.05 
 
 
  
          
 
 
